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In Plasmodium falciparum-infected erythrocyte homogenates, the specific activity of ethanolamine kinase 
(7.6 f 1.4 nmol phosphethanolamine/107 infected cells per h) was higher than choline kinase specific activity 
(1.9 f 0.2 nmol phosphocholine/107 infected cells per h). The K,,, of choline kinase for choline was 79 + 
20 PM, and ethanolamine was a weak competitive inhibitor of the reaction ($ = 92 mM). Ethanolamine 
kinase had a K, for ethanolamine of 188 + 19 FM, and choline was a competitive inhibitor of ethanolamine 
kinase with a very high K, of 268 mM. Hemicholinium 3 inhibited choline kinase activity, but had no effect 
on ethanolamine kinase activity. In contrast, D-Zamino-1-butanol selectively inhibited ethanolamine kinase 
activity. Furthermore, when the two enzymes were subjected to heat inactivation, 85% of the choline kinase 
activity was destroyed after 5 min at 5O”C, whereas ethanolamine kinase activity was not altered. Our results 
indicate that the phosphorylation of choline and ethanolamine was catalyzed by two distinct enzymes. The 
presence of a de novo phosphatidylethanolamine Kennedy pathway in P. falciparum contributes to the 
bewildering variety of phospholipid biosynthetic pathways in this parasitic organism. 
Malaria (Plasmodium falciparum) Choline kinase Ethanolamine kinase Phospholipid 
1. INTRODUCTION 
Plasmodium is a protozoon, which is the agent 
of malaria, one of the most lethal parasitic diseases 
in the world. During the pathological erythrocytic 
stage, there is a considerable increase (as much as 
5OOOro) in the erythrocyte phospholipid content, 
especially PC and PE [1,2]. We have previously 
detected and quantified the different pathways of 
phospholipid metabolism in P. knowlesi [3], as 
well as in,P. falciparum-infected erythrocytes [4]. 
Parasitized erythrocytes are capable of incor- 
porating high amounts of labeled ethanolamine. 
Abbreviations: PC, phosphatidylcholine; PE, phospha- 
tidylethanolamine; PS, phosphatidylserine; PhoCh, 
phosphorylcholine; PhoEth, phosphorylethanolamine 
However, the rate of PE formation by PS decar- 
boxylation is enough to satisfy most of the parasite 
requirements for this phospholipid. Since 
ethanolamine is present in plasma at very low 
levels [5] and quasi-absent from the culture 
medium of P. falciparum [6], labeled 
ethanolamine incorporation could merely reflect 
either a Ca*+-dependent base-exchange mechanism 
or a utilization of ethanolamine instead of choline, 
via the PC Kennedy pathway [7]. 
The problem is crucial since PE is the 
phospholipid most increased in absolute amounts, 
after infection by Plasmodium. However, until 
now, it has never been demonstrated that a biosyn- 
thesis of PE via the Kennedy pathway also exists in 
situ in Plasmodium-infected erythrocytes. 
Here, we investigate the CharaLLeristics of 
ATP : choline phosphotransferase (choline kinase, 
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EC 2.7.1.32) and ATP : ethanolamine phospho- 
transferase (ethanolamine kinase, EC 2.7.1.82), 
the first-step catalyzing enzymes of the de novo 
synthesis of PC and PE, respectively. The nearly 
complete absence of competition between the two 
types of substrate for the enzymes, as well as the 
characteristics of these two enzymatic activities 
under various conditions, clearly indicate that two 
distinct enzymes exist and that there is a biosyn- 
thesis of PE by the Kennedy pathway in situ in the 
parasitic protozoon P. falciparum. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
[methyl-‘4C]Choline and [2-14C]ethan-l-01-2- 
amine were purchased from Amershaml Choline 
chloride, ethanolamine, hemicholinium 3, were 
supplied by Sigma, and D-2-amino-1-butanol came 
from Ventron. Dowex AG 1X8 (chloride form), 
100-200 mesh, was obtained from Biorad and 
RPM1 1640 from Gibco (France). All reagents 
were of analytical grade. 
2.2. Biological material 
AB+ human blood or AB+ human serum came 
from the Blood Bank of Montpellier (France). 
The Nigerian strain of P. falciparum (Dr W.H. 
Richard, Wellcome Research Laboratories, 
Beckenham, England [S]) was maintained by serial 
passages in AB+ human erythrocytes uspended in 
complete medium (RPM1 1640 supplemented with 
25 mM Hepes buffer, pH 7.4, and 10% AB+ 
serum) at 37”C, using the petri-dish candle-jar 
method [6]. For experimentation, infected cells 
were pelleted at 7000 x g - min, then lyzed by an 
equal volume of water and further sonicated in a 
probe-type sonicator (Branson B 30 sonifier) for 
30 s at 4°C. Homogenates could be stored at 
- 20°C for several days. In some experiments, the 
crude hemolysate of infected erythrocytes was fur- 
ther fractionated to separate the parasite cytosol 
fraction from the parasite membrane structures, as 
described in [9]. 
2.3. Enzyme assay 
Choline kinase (ATP : choline phosphotrans- 
ferase) (EC 2.7.1.32) was determined as in a 
previous characterization done in infected erythro- 
cytes [9]. Unless otherwise specified, the incuba- 
218 
tion mixtures contained 125 mM Tris-HCl, pH 
7.9, 10 mM ATP, 10 mM MgC12, 5 mM EGTA, 
0.5 mM [methyl-14C]choline (0.9 Ci/mol) and 
20 ~1 of enzyme extract in a final volume of 200 ~1. 
After 45 min at 37”C, the reaction was stopped at 
4°C. Routinely, each reaction mixture was applied 
to a column (0.55 x 2.5 cm) of Dowex AG 1X8, 
OH- form, 100-200 mesh, ion-exchange resin. 
After washing with 10 ml water, PhoCh was eluted 
with 0.5 ml of 1 N NaOH, followed by 1.5 ml of 
0.1 N NaOH. In preliminary experiments, cellular 
lipids were extracted as in [lo] to verify that neither 
CDP-choline nor PC was formed during the in- 
cubation procedure. 
Ethanolamine kinase (ATP : ethanolamine 
phosphotransferase, EC 2.7.1.82) was determined 
according to Weinhold and Rethy [ 111. Incubation 
mixtures contained 60 mM Tris-HCl, pH 8.5, 
3 mM ATP, 3 mM Mg(CHsCOO)z, 0.2 M KCl, 
1.2 mM [2-14C]ethanolamine (2.2 Ci/mol) and 
20 pl of enzyme in a final volume of 200 ~1. The 
reaction was started by adding the enzyme extract, 
and after 45 min at 37”C, it was stopped by cool- 
ing to 4°C and adding 50~1 ethanol. PhoEth was 
separated from ethanolamine by paper 
chromatography (Whatman 3MM) in 2.7 M am- 
monium acetate buffer, pH 5.0/95% ethanol (3-7, 
v/v) [12]. Authentic standards were also applied 
for migration. After visualization by a ninhydrin 
spray, the appropriate spots were cut from the 
paper chromatograms and counted after addition 
of scintillation cocktail (Packard no.299) in a 
Packard 460 CD spectrometer. 
Results are expressed as nmol/lO’ infected cells 
per h, since results expressed as nmol/mg protein 
would lead to imprecise and irreproducible results 
depending on parasitemia (i.e. the percentage of 
infected cells) of the original suspension. 
3. RESULTS 
In previous studies, we have determined the con- 
ditions of choline kinase assay in P. falciparum- 
infected erythrocytes [9]. Ethanolamine kinase ac- 
tivity was here assayed according to Weinhold and 
Rethy [ll]. Under our assay conditions, radioac- 
tive choline and ethanolamine were only 
recovered, after incubation, as PhoCh and 
PhoEth, respectively. We particularly checked that 
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neither CDP-choline (or CDP-ethanolamine), nor 
PC (or PE) was formed. 
P. falciparum-infected erythrocyte homogenates 
phosphorylate ethanolamine more actively than 
choline, at specific activities of 7.6 f 1.4 (n = lo), 
and 1.9 + 0.2 (n = 15) nmol/lO’ infected cells per 
h, respectively. Very little kinase activity was 
found in normal uninfected erythrocytes: 70 pmol 
PhoEth/lO’ cells per h and 6 pmol PhoCh/lO’ 
cells per h, which is less than 1% of the activity of 
infected cells. Therefore, results are expressed as 
nmol product per infected cells. 
After fractionation of P. falciparum-infected 
erythrocyte homogenates, choline and ethanol- 
amine kinase activities were specifically located in 
the cytosol fraction and neither activity was 
recovered in the membrane fraction. A quite com- 
parable activity was found in the crude homo- 
genate (not shown). Therefore, we routinely 
assayed choline and ethanolamine kinase activities 
in infected erythrocyte homogenates. 
When ethanolamine kinase was assayed under 
the same conditions as choline kinase (i.e. at 
10 mM ATP and MgC12, pH 7.9) the activity of 
:holine Kinase 
A 
10 20 30 25 50 75 loo 125 
l/[CHOLINE] tmM_‘) l/[ETHANOLAMINE] tmM_‘) 
ethanolamine kinase was not significantly dif- 
ferent, whereas when choline kinase was assayed 
under the same conditions as ethanolamine kinase 
(3 mM ATP and Mg(CHK00)2, pH 8.5), the ac- 
tivity of choline kinase was 57% reduced, in- 
dicating that the conditions for ethanolamine 
kinase assay could not be applied to the assay of 
choline kinase. 
When the homogenates were incubated with 
various concentrations of ,&-mercaptoethanol 
(from 0.1 to 40 mM), no increase in choline kinase 
activity was found, differing from choline kinase 
activity in yeast [13]. With the same ,&- 
mercaptoethanol concentrations, ethanolamine 
kinase activity was also unchanged. 
3.1. Influence of substrate concentrations: 
cross-inhibition studies 
The apparent K,,, of choline kinase for choline 
was 79 f 20,uM (n = 6), whereas the K,,, of 
ethanolamine kinase for ethanolamine was slightly 
higher, 188 f 19pM (n = 3). A possible competi- 
tion between the two types of substrate for the en- 
zymes was investigated. Fig.lA shows that 
than&mine Kinase 
B 
lin* 1 
MJ 
Fig.1. Substrate competition studies for choline and ethanolamine kinase activities in P. fulcipurum-infected 
erythrocytes. Double-reciprocal plots of the initial velocities of: (A) choline kinase in the presence of increasing 
ethanolamine concentrations (M); the homogenate fraction contained 1.7 x 10’ infected cells per assay; (B) 
ethanolamine kinase in the presence of increasing choline concentrations (A---A); the homogenate fraction contained 
1.35 x 10’ infected cells per assay. 
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Fig.2. Differential inhibition of choline and ethanolamine kinases by hemicholinium 3 and D-Zamino-1-butanol. The 
extracts, containing 10’ infected cells, were incubated as described in section 2, except hat the indicated concentrations 
of hemicholinium 3 or D-Zamino-1-butanol were added. Results are the means of two experiments each carried out 
in duplicate. Control activities were 2.6 + 0.1 and 18.0 k 0.3 nmol/lO’ infected cells per h for choline kinase (ti) 
and ethanolamine kinase (A---A), respectively. 
ethanolamine was a competitive inhibitor of 
choline kinase. However, the Ki of 92 mM, ob- 
tained from linear extrapolations of a replot of the 
Lineweaver-Burk slopes vs ethanolamine concen- 
tration [14], indicates a very low affinity of this ____---- --4--... 
‘: 
-_+____-p.______.~ 
\ -4 -4 
r/ * 
35 40 45 50 55 60 
PREINCUBATION TEMPERATURE (%I 
substrate for choline kinase. Similarly, choline was 
a very weak competitive inhibitor of ethanolamine 
kinase, with a high Kr of 268 mM (fig.lB). 
Therefore, in both cases, choline and 
ethanolamine kinases have very high specificities 
for their natural substrate, without any ap- 
preciable affinity for ethanolamine or choline, 
respectively. 
3.2. Differential inhibition of choline and 
ethanolamine kinases by two structural 
analogs 
Fig.2 shows that hemicholinium 3 significantly 
and specifically decreased choline kinase activity 
Fig.3. Heat-inactivation of choline and ethanolamine 
kinases of P. falciparum-in fected erythrocytes. 
Homogenates of infected erythrocytes (7.7 x lo6 
parasitized cells per assay) were preincubated for 5 min 
at the specified temperatures, then removed and assayed 
at 37°C for kinase activities as described in section 2. 
Duplicate experiments were repeated at least twice. 
Control activities were 1.19 + 0.02 and 3.6 f 
0.2 nmol/lO’ infected cells per h for choline kinase 
(ti) and ethanolamine kinase (A---A), respectively. 
Volume 202, number 2 FEBS LETTERS July 1986 
by 16% at 0.5 mM to as much as 70% at 10 mM. 
But similar concentrations of hemicholinium 3 had 
no effect on ethanolamine kinase activity. In con- 
trast, D-2-amino-1-butanol did not affect choline 
kinase activity whereas ethanolamine kinase was 
reduced by 10 to 76% in the range of 0.1 and 
10 mM, respectively. 
3.3. Heat inactivation 
When homogenates were preincubated at 45°C 
for various periods and assayed for kinase ac- 
tivities at 37”C, both of the kinase activities were 
destroyed at the same rate, with 50% of the activi- 
ty remaining after 30 min of preincubation. 
However, in other experiments, the homogenates 
were preincubated for 5 min at various 
temperatures, ranging from 37 to 6O”C, before 
assaying for kinase activities at 37°C. Fig.3 shows 
that choline kinase activity was 85% destroyed 
after 5 min at 5O”C, whereas ethanolamine kinase 
was very resistant o heat, since 90% of the activity 
was still recovered after preincubation at 60°C. 
4. DISCUSSION 
The major finding of this study is the clear 
evidence that choline kinase and ethanolamine 
kinase activities are separate in the protozoon 
Plasmodium. The apparent K,,, values of choline 
and ethanolamine kinases for choline and 
ethanolamine do not differ greatly: 79 f 20pM (n 
= 6) and 188 f 19,uM (n = 3), respectively. 
However, experiments designed to test for com- 
petition between the two substrates for each en- 
zyme activity clearly indicate that choline and 
ethanolamine phosphorylations involve two 
distinct active sites. The Ki of choline kinase in- 
hibition by ethanolamine was more than 
1 lOO-times as high as the Km of choline kinase ac- 
tivity, already indicating that the catalytic site of 
choline kinase has a quite low affinity for 
ethanolamine. Similarly, the catalytic site of 
ethanolamine kinase is also unable to recognize 
choline effectively, since the Ki of ethanolamine 
kinase inhibition by choline was more than 
1400-times as high as the K,,, of ethanolamine 
kinase for ethanolamine. 
Wittenberg and Kornberg [13] have shown that 
decreasing the number of N-methyl groups in 
choline increases the K,,, of choline kinase for these 
substrates. Hence, the 3 methyl groups appear to 
be crucial for the transformation of choline by 
choline kinase. Similarly, our experiments show 
that the primary amine group of ethanolamine 
seems to be essential to its phosphorylation by 
ethanolamine kinase. In fact, it should be noted 
that, under our conditions of pH assay, choline 
had a permanent charge, and that 84% of the 
ethanolamine was in the protonated form at pH 
8.5 (pK = 9.2 at 36°C [IS]). This indicates that the 
high specificity of the two kinases for their respec- 
tive substrates cannot result from a mere charge 
phenomenon. 
Several studies have previously reported the 
ability of choline kinase preparations to 
phosphorylate ethanolamine at much lower rates 
[12,16,17]. Our data show that under our defined 
and differing assay conditions, extracts of P. 
falciparum-infected erythrocytes phosphorylated 
ethanolamine at a higher rate (more than 4-fold) 
than choline. Furthermore, when assayed under 
the same conditions as ethanolamine kinase, 
choline kinase activity was decreased by 57%. 
Thus, the two kinase activity require different 
assay conditions, already suggesting the involve- 
ment of two enzyme catalytic sites. 
Other evidence for two distinct kinase activities 
was provided by their differential inhibition by two 
structural analogs. Hemicholinium 3, which like 
choline has a quaternary ammonium group, in- 
terferes with various reactions involving choline as 
substrate, such as acetylation in the nervous system 
[ 181, phosphorylation in various tissues [ 19,201, 
and transport of choline in erythrocytes [21,22]. 
Hemicholinium 3 specifically inhibited choline 
kinase activity but had no effect on ethanolamine 
kinase activity. In contrast, D-2-amino-1-butanol, 
which we previously reported as an inhibitor of PE 
biosynthesis in Plasmodium-infected erythrocytes 
[23], selectively inhibited ethanolamine kinase 
activity. 
Lastly, choline and ethanolamine kinase showed 
quite different stabilities after heating. Most of the 
choline kinase was destroyed by heating, whereas 
ethanolamine kinase activity was entirely 
recovered after 5 min at 60°C (see fig.3). Hence, 
this difference in stability clearly distinguishes the 
two kinase activities. 
Although the two kinase activities were not 
physically separated, the many lines of evidence 
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provided by our study clearly demonstrate that two special program for Research and Training in 
distinct enzymes are involved in the phosphoryla- Tropical Diseases (grant T16-181-M2-15A) and the 
tion of choline and ethanolamine in Plasmodium- Ministere de la Recherche et de I’Industrie 
infected erythrocytes. (no.82-L-0785). 
Until now, a de novo biosynthesis of PE via the 
Kennedy pathway has never been demonstrated in 
this parasite. In a previous work, using a wide 
variety of approaches, we were unable to 
distinguish between the two last-step catalyzing en- 
zymes in the de novo synthesis of PC and PE. 
Nevertheless, it appears that Plasmodium contains 
the necessary enzymatic machinery for synthesiz- 
ing PC and PE [24]. The high level of a specific 
ethanolamine kinase activity shown here, as well as 
the high incorporation of labeled ethanolamine in- 
to PE by Plasmodium-infected erythrocytes [3], 
strongly suggest hat a de novo PE biosynthesis by 
the Kennedy pathway takes place in situ in 
parasitized cell. 
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